维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Callander N"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Immunohistochemical identification of tissue factor in solid tumors显示文摘	Callander NS Varki N Rao LV	1992	Cancer1992，70，5：	1
2	Hematological improvement(HI) bv TLK199(TelintraR), a novel glutathione analog, in myelndysplastie syndrome: results of a phase 2 study results 显示文摘	Raza A Callander N Ochoa L	2005	Blood2005，106，：	1
3	A randomized trial of lenalidomide plus high-dose dexamethasone (RD) versus lenalidomide plus low-dose dexamethasone (Rd) in newly diagnosed multiple myeloma (EdA03): a trial coordinated by the Eastern Cooperative Oncology Group 显示文摘	Rajkumar SV Jacobus S Callander N	2007	Blood2007，110，：	1
4	AML - 1A and AML - 1B regulation of MIP - 1 alpha expression in multiple myeloma显示文摘	CHOI S J OBA T CALLANDER N S	2003	Blood2003，101，10：	1
5	Poiyphenols Inhihit Hepatitis C Virus Entry hy a New Mechanism of Action 显示文摘	CALLAND N SAHUC M E BELOUZARD S	2015	Journal of Virolggy2015，89，19：	1
6	Peripheral blood stem cell mobilization with cyclophosphamide in combination with G - CSF, GM - CSF, or sequential GM - CSF/G - CSF in non -Hodgkin's lymphoma patients: a randomized prospective study 显示文摘	Gazitt Y Callander N Freytes CO	2000	J Hematother Stem Cell Res2000，9，5：	1
7	Severe,late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis显示文摘	POLLACK M S SPEEG K V CALLANDER N S	2005	Human Immunology2005，66，1：	1
8	Immunohistochemical identification of tissue factor in solid tumors显示文摘	Callander NS Varki N Rao LV	1992	Cancer1992，70，5：	1
9	A randomized phase III trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma: a trial coordinated by the Eastern Cooperative Ontology Group显示文摘	Rajkumar SV Jacobus S Callander N	2006	Blood2006，108，4：	1
10	Bortezomibresistant nuclear factor-kappaB activity in multiple myeloma cells显示文摘	Markovina S Callander N S O'Connor S L	2008	Mol Cancer Res2008，6，8：	1
11	Outcome of elderly patients 70 years and older with newly diagnosed myeloma in the ECOG randomized trial of lenalidomide/high-dose dexa- methasone ( RD ) versus lenalidomide/low-dose dexamethasone (Rd) 显示文摘	Jacobus S Callander N Siegel D	2010	Haematologica2010，95，2：	1
12	Immunohistochemical identification of tissue factor in solid tumors显示文摘	CALLANDER NS VARKI N RAOL V	1992	Cancer1992，70，5：	1
13	( ) Epigallo catechin-3-gallate is a new inhibitor of hepatitis C virus entry显示文摘	Calland N Albecka A Belouzard S	2012	Hepatology2012，55，3：	1
14	Lenalidomide plus highdose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma:an open-label randomized controlled trial显示文摘	Rajkumar SV Jacobus S Callander N	2010	Lancet Oncol2010，11，：	1
15	Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma:an open-label randomized controlled trial显示文摘	Rajkumar SV Jacobus S Callander N	2010	Lancet Oncol2010，11，1：	1
16	Immunohistochemical identification of tissue factor in solid tumors显示文摘	Callander N Varki N Rao VM	1992	Cancer1992，70，：	1
17	Acetyl-L-carnitine(ALCAR) for the prevention of chemotherapy-induced periph-eral neuropathy in patients with relapsed or refractory multiplemyeloma treated with bortezomib,doxorubicin and low-dosedexamethasone : a study from the Wisconsin Oncology Network显示文摘	Callander N Markovina S Eickhoff J	2014	Cancer Chemother Pharmacol2014，74，4：	1
18	Immunohistochemical identification of tissue factor in solid tumors显示文摘	Callander N S Varki N Rao L	1992	Cancer1992，70，5：	1
19	Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma显示文摘	RAJKUMAR S V JACOBUS S CALLANDER N S	2010	Lancet Oncol2010，11，：	1
20	(-)-Epigallocatechin-3-Gallate Is a New Inhibitor of Hepatitis C Virus Entry Hepatology显示文摘	Calland N Albecka A Belouzard S Wychowski C Duverlie G Descamps V Hober D Dubuisson J RouilléY Séron K	2012	55(3):720-7292012，55，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示